Medicine shortages in Italy
Live register of drug shortage notices in Italy, aggregated daily from official regulator publications and linked back to every source.
Regulators list each strength and pack separately, so one medicine can carry several notices — compare official per-medicine tallies against “Medicines affected”. How we count
Latest shortage notices in Italy
| Medicine | Status | Severity | Since | Source |
|---|---|---|---|---|
| Sevelamer | anticipated | medium | 8 Nov 2026 | AIFA |
| Aprepitant | anticipated | critical | 7 Nov 2026 | AIFA |
| Adalimumab | anticipated | critical | 7 Nov 2026 | AIFA |
| Montelukast | anticipated | medium | 7 Nov 2026 | AIFA |
| Levetiracetam | active | medium | 6 Nov 2026 | AIFA |
Official sources for Italy
- Agenzia Italiana del Farmaco — Carenze (AIFA) — official register · last checked 8 Nov 2026
- Italy AIFA Liste di Trasparenza (AIFA) — official register · last checked 13 Oct 2026
Frequently asked questions
How many medicines are in shortage in Italy?
Italy currently has 2924 active medicine shortage notices and 217 anticipated, of which 516 are rated critical. Figures update daily from official regulator publications.
Who reports medicine shortages in Italy?
Official shortage notices for Italy are published by Agenzia Italiana del Farmaco — Carenze (AIFA), Italy AIFA Liste di Trasparenza (AIFA). Mederti checks these sources daily and links every notice back to the original publication.
How current is this Italy shortage data?
Mederti scrapes Italy's official shortage register daily. Each notice carries the regulator's own dates; the list on this page reflects the most recent successful update.
Track Italy shortages that matter to you
Watchlists, email alerts, alternatives and cross-country comparison — free for individual pharmacists and clinicians.
Create a free accountData is aggregated from official sources and provided for information only. Mederti is not affiliated with or endorsed by any regulator. Verify with AIFA before clinical or procurement decisions.